Subscribe to magazine
Subscribe to newsletters
Roundtable: Stereotactic Breast Imaging
Technology Report: Artificial Intelligence (NEW)
Technology Report: CT
Technology Report: Digital Radiography
Technology Report: Enterprise Imaging (NEW)
Technology Report: MRI
Whitepaper: Interoperability Challenge and Solutions (NEW)
Themed Blogs: Greg Freiherr
Computed Tomography (CT)
Digital Radiography (DR)
Magnetic Resonance Imaging (MRI)
Radiation dose management
Breast Biopsy Systems
Ultrasound Women's Health
Clinical decision support
Flat panel displays
Imaging software development
Remote viewing systems
Vendor neutral archives (VNA)
Oncology information management systems (OIMS)
Treatment planning software/systems
Radiopharmaceuticals and Tracers
Avid Radiopharmaceuticals Inc.
May 18, 2012
Dyeing to Paint the Alzheimer’s Brain
May 18, 2012 — In April the U.S. Food and Drug Administration (FDA) approved Avid Radiopharmaceuticals’ (now part of...
February 09, 2012
| Dave Fornell
The Race to Image Alzheimer’s Disease
Several positron emission tomography (PET) imaging agents are being developed to visualize Alzheimer’s disease in the...
July 19, 2011
Florbetapir "Imaging to Autopsy" Study Awarded de Leon Prize in Neuroimaging
July 19, 2011 – The study "Use of Florbetapir-PET for Imaging beta-amyloid Pathology," published in the Jan. 19, 2011,...
January 21, 2011
FDA Panel Recommends Conditional Approval for PET Agent
January 21, 2011 — The U.S.
October 02, 2007
Avid Holds Trial for Imaging Compound
October 3, 2007 - Avid Radiopharmaceuticals Inc., a product-focused molecular imaging company, announced today that e
June 14, 2007
Molecular Imaging of Diabetes Selected as 2007 Small Animal Image of the Year
June 15, 2007 - Avid Radiopharmaceuticals Inc.
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions